Health ❯ Healthcare ❯ Pharmacology

Medications

GLP-1 Receptor Agonists Semaglutide GLP-1 Drugs GLP-1 Agonists Weight Loss Drugs Metformin Gabapentin Weight Loss Medications PCSK9 Inhibitors Tranexamic Acid Antidepressants Empagliflozin GLP-1 Medications Glucagon-like Peptide-1 Receptor Agonists Bupropion Bitopertin Citisine Aspirin Tirzepatide Nasal Decongestants Levodopa Paracetamol Antiresorptive Drugs Cardiovascular Medications Side Effects Topiramate Diabetes Medications Canagliflozin Antihypertensives Diabetes Treatments Magnesium Sulfate Intranasal Insulin Mineralocorticoid Receptor Antagonists Proton Pump Inhibitors Dementia Risk Dopamine Agonists and Alternatives Metoclopramide and Erythromycin Antihypertensive Drugs SGLT2 Inhibitors Varenicline Blood Pressure Medications Retatrutide Eptinezumab Obesity Treatments

Meta-Analysis Finds Tirzepatide Produces Largest Average Weight Loss Among FDA‑Approved GLP‑1s

Linked to dual GLP‑1/GIP targeting, tirzepatide showed larger average weight loss in trials with uncertain post‑treatment durability.

Finerenone Slows Kidney Decline in Non‑Diabetic CKD, Trial Shows

Oral GLP‑1 Approval and New Trials Push Weight‑Loss Drugs Into Mass Market

Largest Study of Severe Pregnancy Sickness Confirms Key Gene and Finds Six New Leads

Preliminary Study Links GLP-1 Drugs to Fewer ER Visits in Chronic Migraine

Global Study Finds Wide Gaps in Use of Antenatal Magnesium Sulfate, With Steroids Applied More Consistently

Metformin Linked to 37% Lower Odds of Intermediate Macular Degeneration in Diabetic Patients

Oral Semaglutide Cuts Serious Heart-Failure Events 22% in Type 2 Diabetes With Heart Failure

AGA Issues Gastroparesis Guideline With 12 Conditional Recommendations

New U.S. Blood Pressure Guidelines Urge Earlier Treatment as Study Backs Lower Targets

Metformin Linked to Lower Dementia and Mortality Risks in Overweight, Obese Adults

Varenicline-Bupropion Combination Doubles Treatment Effectiveness for Alcohol Use Disorder